Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01929785 · ClinicalTrials.gov registry record

BIIR Gene to Manage Heart Allograft Patients

A clinical trial of Cardiac Transplant Failure, sponsored by Baylor Research Institute.

Completed
Registry status
56
Enrollment target
1
Study location

NCT01929785: Completed study of Cardiac Transplant Failure, sponsored by Baylor Research Institute.

NCT01929785 is a study of Cardiac Transplant Failure that has completed, run by Baylor Research Institute. The registered enrollment target is 56 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01929785, a study of Cardiac Transplant Failure, has completed, sponsored by Baylor Research Institute.

COMPLETED
Registry status
56 participants
Enrollment target
1
Study location

Study Summary

This is a single center observational study. Duration of the study is 1 year. Participants will be followed in 2 groups. Group 1 will include all patients who have undergone a heart transplant, through the first year post transplant. Group 2 will include heart transplant recipients from 1 year to 2 years post transplant. Groups will be enrolled simultaneously. It is anticipated each group will have 25 participants.

Primary Outcome

To systematically collect blood samples from heart allograft recipients who are 0 -2 years post-transplant for eventual screening of blood cell gene activity, in order to identify diagnostically useful biomarkers that can help distinguish among multiple possible clinical presentation, e.g., acute rejection, antibody mediated rejection, infection, coronary artery disease, a variety of potential causes for heart dysfunction.).

Conditions Studied

Study Locations (1)

Texas

  • Baylor University Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2009-12
Est. Completion 2013-11
Baylor Research Institute

180 total trials

What the finished NCT01929785 record still lists

NCT01929785 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target.

The record links to 1 condition, with Cardiac Transplant Failure appearing as the primary indexed condition, and to 0 interventions.

NCT01929785 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT01929785 about?

NCT01929785 is a clinical study titled "BIIR Gene to Manage Heart Allograft Patients". This is a single center observational study. Duration of the study is 1 year. Participants will be followed in 2 groups. Group 1 will include all patients who have undergone a heart transplant, through the first year post transplant. Group 2 will include heart transplant recipients from 1 year to 2 ...

What is the current status of trial NCT01929785?

This trial is currently completed. The enrollment target is 56 participants. The study started on 2009-12. Estimated completion is 2013-11.

What conditions does trial NCT01929785 study?

This clinical trial studies the following conditions: Cardiac Transplant Failure.

Who is sponsoring clinical trial NCT01929785?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01929785 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01929785, the US trial registry maintained by the National Library of Medicine. NCT01929785 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.